The entrepreneurial sourcing and operational experience of Arix Bioscience and the diverse range of life science opportunities under consideration have proved attractive to investors.
Arix Bioscience raised substantial, initial operational and investment capital from a range of investors, led by Woodford Investment Management LLP. This capital enabled us to create a truly flexible business platform.
Our evergreen structure permits further capital raising, which will continue as our business develops. The company has access to an extensive pipeline of deals and current market conditions are creating further opportunities.